Company Filing History:
6 out of 2,359 
1 out of 1 
6 out of 832,966 Years Active: 2009-2020
Title: Craig Beattie: Innovative Thinker in Cancer Treatment
Introduction
Craig Beattie is a distinguished inventor located in Chicago, IL, who has made significant contributions to the field of cancer treatment through his groundbreaking inventions. With a remarkable portfolio of 13 patents, Beattie's work focuses on the development of innovative methods and compositions that aim to inhibit and treat various forms of cancer.
Latest Patents
Among Beattie's most recent patents are several noteworthy inventions. The first patent, titled "Compositions comprising cupredoxins for treating cancer," discloses methods and materials designed to kill and/or inhibit the growth of cancer cells via the preferential entry of a cytotoxic compound. This innovative approach utilizes protein transduction domains derived from cupredoxins, such as the p18 and p28 truncations of azurin, to deliver these compounds effectively.
Another significant patent, "Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways," relates to the development of compositions that include chemopreventive agents derived from cupredoxins. These compositions aim to prevent or inhibit the development of premalignant lesions in mammalian cells, contributing greatly to cancer prevention efforts.
Career Highlights
Throughout his career, Craig Beattie has worked with esteemed institutions, including the University of Illinois, where he furthered his research and innovations. His valuable contributions in the academic and scientific communities have established him as a notable figure in cancer research.
Collaborations
Beattie’s inventive journey has led him to collaborate with talented individuals in the field, including Tapas Das Gupta and Tohru Yamada. These collaborations have enriched his work, enabling him to explore new ideas and enhance the impact of his innovations in cancer treatment.
Conclusion
With his 13 patents and ongoing research, Craig Beattie continues to push the boundaries of innovation in cancer treatment. His contributions not only showcase his commitment to combating cancer but also illustrate the potential of innovative thinking to make a meaningful difference in the medical field. As he progresses in his endeavors, the scientific community eagerly anticipates further breakthroughs from this accomplished inventor.